| P2093 | author name string | Simon C Watkins | |
| | Adrian T Ting | |
| | Dong Hu | |
| | John Bertin | |
| | Linda M McAllister-Lucas | |
| | Peter C Lucas | |
| | Shufang Gu | |
| | Kevin P Foley | |
| | Katherine I Oravecz-Wilson | |
| | Peter J Gough | |
| | Danielle N Alfano | |
| | Vincent J Concel | |
| | Linda R Klei | |
| | Rachel E Bridwell | |
| | Kelly M Bailey | |
| | Phillip C Delekta | |
| | Matthew Van Beek | |
| | Emily M Hess | |
| | Robert Panek | |
| P2860 | cites work | Card10 is a novel caspase recruitment domain/membrane-associated guanylate kinase family member that interacts with BCL10 and activates NF-kappa B | Q24290946 |
| | Nucleotide exchange factor GEF-H1 mediates cross-talk between microtubules and the actin cytoskeleton | Q24292682 |
| | CYLD regulates angiogenesis by mediating vascular endothelial cell migration | Q24301471 |
| | T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20 | Q24307779 |
| | CYLD negatively regulates cell-cycle progression by inactivating HDAC6 and increasing the levels of acetylated tubulin | Q24314876 |
| | CARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells | Q24675332 |
| | Mechanisms regulating endothelial permeability | Q26866511 |
| | Structural analysis of phenothiazine derivatives as allosteric inhibitors of the MALT1 paracaspase | Q27685382 |
| | CYLD - a deubiquitylase that acts to fine-tune microtubule properties and functions | Q28072361 |
| | Bimp1, a MAGUK family member linking protein kinase C activation to Bcl10-mediated NF-kappaB induction | Q28198772 |
| | Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB | Q28201706 |
| | Post-translational modifications regulate microtubule function | Q29036830 |
| | Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase | Q29615195 |
| | Thrombin signalling and protease-activated receptors | Q29619601 |
| | Impedance analysis of GPCR-mediated changes in endothelial barrier function: overview and fundamental considerations for stable and reproducible measurements | Q30373402 |
| | The CARMA3-Bcl10-MALT1 signalosome promotes angiotensin II-dependent vascular inflammation and atherogenesis | Q34074217 |
| | T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1. | Q34174201 |
| | The CARD11-BCL10-MALT1 (CBM) signalosome complex: Stepping into the limelight of human primary immunodeficiency | Q34206229 |
| | Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines. | Q34211312 |
| | Cytoskeletal regulation of pulmonary vascular permeability | Q34377340 |
| | Thrombin-dependent NF-{kappa}B activation and monocyte/endothelial adhesion are mediated by the CARMA3·Bcl10·MALT1 signalosome | Q34438768 |
| | Analysis of microtubule dynamic instability using a plus-end growth marker | Q34547668 |
| | 'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage | Q34686193 |
| | The proteolytic activity of the paracaspase MALT1 is key in T cell activation | Q34748769 |
| | Cytoskeletal mechanisms regulating vascular endothelial barrier function in response to acute lung injury | Q35212825 |
| | RhoA and ROCK mediate histamine-induced vascular leakage and anaphylactic shock. | Q35377560 |
| | Bcl10 and Malt1 control lysophosphatidic acid-induced NF-kappaB activation and cytokine production | Q35575886 |
| | Bcl10 plays a critical role in NF-kappaB activation induced by G protein-coupled receptors. | Q35575890 |
| | MALT1 Protease Activity Is Required for Innate and Adaptive Immune Responses | Q35597435 |
| | CARMA3 deficiency abrogates G protein-coupled receptor-induced NF-{kappa}B activation | Q35741899 |
| | CARMA1, BCL-10 and MALT1 in lymphocyte development and activation. | Q35762426 |
| | Development of new Malt1 inhibitors and probes. | Q35991775 |
| | Signaling mechanisms regulating endothelial permeability | Q36350076 |
| | The roles of proteinase-activated receptors in the vascular physiology and pathophysiology. | Q36649442 |
| | Microtubule-associated proteins as targets in cancer chemotherapy | Q36823252 |
| | Genetic errors of the human caspase recruitment domain-B-cell lymphoma 10-mucosa-associated lymphoid tissue lymphoma-translocation gene 1 (CBM) complex: Molecular, immunologic, and clinical heterogeneity | Q36973638 |
| | Role of the CARMA1/BCL10/MALT1 complex in lymphoid malignancies | Q36988095 |
| | CXCL8/IL8 stimulates vascular endothelial growth factor (VEGF) expression and the autocrine activation of VEGFR2 in endothelial cells by activating NFkappaB through the CBM (Carma3/Bcl10/Malt1) complex | Q37112245 |
| | Regulation of endothelial junctional permeability | Q37122803 |
| | Truncation of the catalytic domain of the cylindromatosis tumor suppressor impairs lung maturation | Q37165388 |
| | Inflammation and plaque vulnerability | Q37370224 |
| | CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes | Q37448141 |
| | CYLD regulates spindle orientation by stabilizing astral microtubules and promoting dishevelled-NuMA-dynein/dynactin complex formation | Q37587645 |
| | CYLD coordinates with EB1 to regulate microtubule dynamics and cell migration | Q37698907 |
| | MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivo | Q37699271 |
| | Atherosclerosis: current pathogenesis and therapeutic options | Q37953777 |
| | Molecular mechanisms of de novo lumen formation | Q38245882 |
| | MALT1--a universal soldier: multiple strategies to ensure NF-κB activation and target gene expression | Q38495157 |
| | Control of microtubule organization and dynamics: two ends in the limelight | Q38631883 |
| | Dynamic microtubules catalyze formation of navigator-TRIO complexes to regulate neurite extension | Q38971296 |
| | Pharmacologic inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC-DLBCL. | Q39226671 |
| | A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains. | Q39843043 |
| | A20 is a negative regulator of BCL10- and CARMA3-mediated activation of NF-kappaB. | Q40001105 |
| | LIM kinase 1 coordinates microtubule stability and actin polymerization in human endothelial cells | Q40421769 |
| | Microtubule-Associated Protein EB3 Regulates IP3 Receptor Clustering and Ca(2+) Signaling in Endothelial Cells. | Q41531091 |
| | plusTipTracker: Quantitative image analysis software for the measurement of microtubule dynamics | Q42264953 |
| | GEF-H1 is involved in agonist-induced human pulmonary endothelial barrier dysfunction | Q46781644 |
| | The tumor suppressor CYLD regulates microtubule dynamics and plays a role in cell migration. | Q46789192 |
| | Microtubule depolymerization rapidly collapses capillary tube networks in vitro and angiogenic vessels in vivo through the small GTPase Rho. | Q47292754 |
| | Evans blue dye as a marker of albumin clearance in cultured endothelial monolayer and isolated lung | Q50795025 |
| | Finally, MALT1 is a protease! | Q80733950 |
| | The acute respiratory distress syndrome | Q84693193 |
| P433 | issue | 1 | |
| P304 | page(s) | 221-232 | |
| P577 | publication date | 2016-09-01 | |
| P1433 | published in | Cell Reports | Q5058165 |
| P1476 | title | MALT1 Protease Activation Triggers Acute Disruption of Endothelial Barrier Integrity via CYLD Cleavage | |
| P478 | volume | 17 | |